Judith Baars

Summary

Publications:
Baars JE, Kuipers EJ, van Dekken J, van der Woude CJ. Surgery is indicated for persistent enterocutaneous fistulizing Crohn?s disease. Clinical Medicine: Gastroenterology 2008;1:1-3

Baars JE, Siegel CA, Kuipers EJ, van der Woude CJ. Patient?s perspectives important for early anti-TNF treatment in inflammatory bowel Disease. Digestion 2009;79:30-35

Baars JE, Zelinkova Z, Mensink PBF, Markus T, Looman CWN, Kuipers EJ, van der Woude CJ. High therapy adherence but substantial limitations to daily activities amongst members of the Dutch inflammatory bowel disease patients? organization: a patient empowerment study. Aliment Pharmacol Ther 2009;30:864-872

Baars JE, Markus T, Kuipers EJ, van der Woude CJ. Patients? Preferences regarding Shared Decision-Making in the Treatment of Inflammatory Bowel Disease: Results from a Patient-Empowerment Study. Digestion 2010;81:113-119

Siegel CA, Schwartz LM, Woloshin S, Cole EB, Rubin DT, Vay T, Baars JE, Sands BE. When Should Ulcerative Colitis Patients Undergo Colectomy for Dysplasia? Mismatch Between Patient Preferences and Physician Recommendations. Inflamm Bowel Dis. 2010; 16:1658-62.

Baars JE, Siegel CA, van ?t Spijker A, Markus T, Kuipers EJ, van der Woude CJ. Inflammatory bowel disease patients are insufficiently educated about the basic characteristics of their disease and the associated risk of colorectal cancer. Digestive and liver disease 2010; 42(11):777-84

Baars JE, Vogelaar L, Wolfhagen FHW, Biermann K, Kuipers EJ, van der Woude CJ. A short course of corticosteroids prior to surveillance colonoscopy to decrease mucosal inflammation in inflammatory bowel disease patients: results from a randomized controlled trial. Journal of Crohn?s and Colitis 2010; 4(6):661-8.
Baars JE, Looman CWN, Steyerberg EW, Kuipers EJ, van der Woude CJ. Individualized surveillance strategies for colorectal cancer in inflammatory bowel disease, GUT 2010; Dec 13 [Epub ahead of print]

Baars JE, Looman CWN, Steyerberg EW, Beukers R, Tan ACITL, Weusten BLAM, Kuipers EJ, van der Woude CJ. The risk of inflammatory bowel disease related colorectal carcinoma is limited: results from a nationwide nested case-control study. American Journal of Gastroenterology 2011; 106(2):319-28

Baars JE, Kuipers EJ, Dijkstra G, Hommes DW, de Jong DJ, Stokkers PCF, Oldenburg B, Pierik M, Wahab PJ, van Bodegraven AA, van der Woude CJ, and the initiative for Crohn and Colitis. Malignant transformation of perianal- and enterocutaneous fistulas occurs rarely: Results of 17 years of follow-up from The Netherlands. Scand J Gastroenterol. 201146 (3):319-25.

Publications

  1. doi High therapy adherence but substantial limitations to daily activities amongst members of the Dutch inflammatory bowel disease patients' organization: a patient empowerment study
    J E Baars
    Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands
    Aliment Pharmacol Ther 30:864-72. 2009
  2. doi Inflammatory bowel disease-patients are insufficiently educated about the basic characteristics of their disease and the associated risk of colorectal cancer
    Judith E Baars
    Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, Postbus 2040, 3000 CA Rotterdam, The Netherlands
    Dig Liver Dis 42:777-84. 2010
  3. doi Patients' preferences regarding shared decision-making in the treatment of inflammatory bowel disease: results from a patient-empowerment study
    Judith E Baars
    Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands j baars erasmusmc nl
    Digestion 81:113-9. 2010
  4. pmc When should ulcerative colitis patients undergo colectomy for dysplasia? Mismatch between patient preferences and physician recommendations
    Corey A Siegel
    Dartmouth Hitchcock Inflammatory Bowel Disease Center, Lebanon, New Hampshire, USA
    Inflamm Bowel Dis 16:1658-62. 2010
  5. doi A short course of corticosteroids prior to surveillance colonoscopy to decrease mucosal inflammation in inflammatory bowel disease patients: results from a randomized controlled trial
    Judith E Baars
    Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands
    J Crohns Colitis 4:661-8. 2010
  6. pmc Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey
    J E Baars
    Department of Gastroenterology and Hepatology, Erasmus MC, s Gravendijkwal 230, Room Ba 393, 3015 CE Rotterdam, The Netherlands
    J Gastroenterol 47:1308-22. 2012
  7. doi Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation
    Judith E Baars
    Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands
    Inflamm Bowel Dis 18:1634-40. 2012
  8. doi Small bowel carcinoma mimicking a relapse of Crohn's disease: a case series
    J E Baars
    Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands
    J Crohns Colitis 5:152-6. 2011
  9. doi Malignant transformation of perianal and enterocutaneous fistulas is rare: results of 17 years of follow-up from The Netherlands
    Judith E Baars
    Department of Gastroenterology and Hepatology, Erasmus Medical Center, Gravendijkwal 230, Rotterdam, The Netherlands
    Scand J Gastroenterol 46:319-25. 2011
  10. doi The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study
    Judith E Baars
    Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands
    Am J Gastroenterol 106:319-28. 2011

Detail Information

Publications11

  1. doi High therapy adherence but substantial limitations to daily activities amongst members of the Dutch inflammatory bowel disease patients' organization: a patient empowerment study
    J E Baars
    Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands
    Aliment Pharmacol Ther 30:864-72. 2009
    ..Adherence is important for successful treatment in inflammatory bowel disease (IBD) patients. Previous studies demonstrated high prevalence of non-adherence...
  2. doi Inflammatory bowel disease-patients are insufficiently educated about the basic characteristics of their disease and the associated risk of colorectal cancer
    Judith E Baars
    Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, Postbus 2040, 3000 CA Rotterdam, The Netherlands
    Dig Liver Dis 42:777-84. 2010
    ..We assessed patients' knowledge of disease and its associated risks/complications, and their perspectives on current recommendations for colectomy when low-grade dysplasia is found...
  3. doi Patients' preferences regarding shared decision-making in the treatment of inflammatory bowel disease: results from a patient-empowerment study
    Judith E Baars
    Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands j baars erasmusmc nl
    Digestion 81:113-9. 2010
    ..Because data are lacking on the preferences of patients with chronic diseases such as inflammatory bowel disease (IBD), we wanted to assess IBD patients' preferences about being involved in such decisions...
  4. pmc When should ulcerative colitis patients undergo colectomy for dysplasia? Mismatch between patient preferences and physician recommendations
    Corey A Siegel
    Dartmouth Hitchcock Inflammatory Bowel Disease Center, Lebanon, New Hampshire, USA
    Inflamm Bowel Dis 16:1658-62. 2010
    ..The objective was to learn if UC patients' perceptions of their colon cancer risk and if their preferences for elective colectomy match with physicians' recommendations if dysplasia was found...
  5. doi A short course of corticosteroids prior to surveillance colonoscopy to decrease mucosal inflammation in inflammatory bowel disease patients: results from a randomized controlled trial
    Judith E Baars
    Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands
    J Crohns Colitis 4:661-8. 2010
    ..This randomized controlled trial assessed the effectiveness of a low dose of corticosteroids prior to surveillance colonoscopy to decrease mucosal inflammation...
  6. pmc Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey
    J E Baars
    Department of Gastroenterology and Hepatology, Erasmus MC, s Gravendijkwal 230, Room Ba 393, 3015 CE Rotterdam, The Netherlands
    J Gastroenterol 47:1308-22. 2012
    ..We studied patient and disease characteristics of IBD-related CRC in a nationwide IBD cohort in general hospitals. Main outcome parameters were time to develop CRC, and factors associated with early CRC development...
  7. doi Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation
    Judith E Baars
    Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands
    Inflamm Bowel Dis 18:1634-40. 2012
    ..Management of inflammatory bowel disease (IBD) is increasingly focused on mucosal remission. We assessed the prevalence of mucosal inflammation during clinical remission, the clinical consequences, and the impact on disease course...
  8. doi Small bowel carcinoma mimicking a relapse of Crohn's disease: a case series
    J E Baars
    Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands
    J Crohns Colitis 5:152-6. 2011
    ..This case series underlines the necessity of performing a full work up in the diagnosis of CD and to consider small bowel carcinoma in patients with small bowel CD failing medical therapy...
  9. doi Malignant transformation of perianal and enterocutaneous fistulas is rare: results of 17 years of follow-up from The Netherlands
    Judith E Baars
    Department of Gastroenterology and Hepatology, Erasmus Medical Center, Gravendijkwal 230, Rotterdam, The Netherlands
    Scand J Gastroenterol 46:319-25. 2011
    ..We investigated adenocarcinoma originating from perianal and enterocutaneous fistulas in both CD patients and non-CD patients from nine large, mostly tertiary referral, hospitals in The Netherlands...
  10. doi The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study
    Judith E Baars
    Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands
    Am J Gastroenterol 106:319-28. 2011
    ..We performed a nationwide nested case-control study to assess the risk for IBD-related CRC and associated prognostic factors in general hospitals...
  11. pmc Patient's perspectives important for early anti-tumor necrosis factor treatment in inflammatory bowel disease
    Judith E Baars
    Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands
    Digestion 79:30-5. 2009
    ..We assessed the perspectives of patients with inflammatory bowel disease (IBD) concerning the treatment-associated risks/benefits of infliximab...